Successful collection of peripheral blood progenitor cells in patients with acute myeloid leukaemia following early consolidation therapy with granulocyte colony-stimulating factor-supported high-dose cytarabine and mitoxantrone

British Journal of Haematology

Volumn 99, Issue 2, 1997, Pages 386-393

  Schlenk, R F ^a   Dohner H ^a   Pforsich M ^a   Benner, A ^b   Fischer, K ^a   Hartmann, F ^c   Fischer, J Th ^d   Weber, W ^e   Gunzer, U ^f   Pralle, H ^g   Haas, R ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^e KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Germany)

^f UNIVERSITY OF WÜRZBURG   (Germany)

^g JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Acute myeloid leukaemia; Autologous blood progenitor cell transplantation; Autologous bone marrow transplantation; CD34+ cells; Granulocyte colony stimulating factor

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CYTARABINE; ETOPOSIDE; HLA DR ANTIGEN; IDARUBICIN; MITOXANTRONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RETINOIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COLONY FORMING UNIT GM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKAPHERESIS; LEUKOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT;

EID: 9844242907     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.3933207.x     Document Type: Article

References (22)

1. Avvisati, G., Coco, F.L., Diverio, D., Falda, M., Ferrara, F., Lazzarino, M. Russo, D., Petti, M.C. & Mandelli, F. (1996) AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study. Blood, 88, 1390-1398.
2. Bloomfield, C.D., Lawrence, D., Arthur, D.C., Berg, D.T., Schiffer, C.A. & Mayer, K.J. (1994) Curative impact of intensification with high-dose cytarabine (Hil)AC) in acute mydoid leukemia (AML) varies by cytogenetic group. (Abstract). Blood 84,111a.
3. Craig, W., Kay, R., Cutler, R.L. & Lansdorp, P.M. (1993) Expression of Thy-1 on human hematopoietic progenitor cells. Journal of Experimental Medicine, 177, 1331-1342.
4. Douay, L., Mary, J.Y., Giarratana, M.C., Najman, A. & Gorin, N.C. (1989) Establishment of a reliable experimenlal procedure for bone marrow purging with mafosfamid (ASTA Z 7557). Experimental Hematology, 17, 429-432.
5. Draper, N.R. & Smith, H. (1981) Applied Regression Analysis, 2nd edn. John Wiley & Sons, New York.
6. Gilmore, M.J.M.L., Prentice, H.G., Blacklock, H.A., Ma. D.D.F., Janossy, G. & Hoffbrand, A.V. (1982) A technique for rapid isolation of bone marrow mononuclear cells using Ficoll-Metrizoate and the IBM 2991 blood cell processor. British Journal of Haematology, 50, 619-626.
7. Haas, R., Möhle, R., Frühauf, S., Goldschimidt, H., Witt, B., Flentje, M., Wannenmacher, M. & Hunstein, W. (1994) Patient characteristics associated with successful mobilizing cells in malignant lymphoma. Blood, 83, 3787-3794.
8. + hematopoietic progenitor cells. Blood, 85, 1936-1943.
9. Haas, R., Witt, B., Möhle, R., Goldschmidt, H., Hohaus, S., Frühauf, S., Wannenmacher, M. & Hunstein, W. (1995b) Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support. Blood, 85, 3754-3761.
10. Hiddemann, W., Büchner, Th., Essink, M., Koch, O., Stenzinger, W. & van de Loo, J. (1988) High-dose cytosine arabinoside and mitoxantrone: preliminary results of a pilot study with sequential application (S-HAM) indicating a high antileukemic activity in refractory acute leukemias. Oncologieit, 11, 10-12.
11. Juttner, C.A., To, L.B., Bardy, P.C., Dyson, P.G., Hallock, D.N. & Kimber, R.J. (1988) Early lympho-hematopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia. Transplantation Proceedings, 20, 40-42.
12. Körbling, M., Fliedner, T.M., Holle, R., Magrin, S., Baumajin, M., Holdermann, K. & Eberhardt, K. (1991) Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: influence of source and cell composition of the autograft on hematopoietic reconstitution and disease free survival. Bone Marrow Transplantation, 7, 343-349.
13. Lu, L., Walker, D., Broxmeyer, H.E., Hoffmann, R., Hu, W. & Walker, E. (1987) Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with MY10 and major histocompatibility class II monoclonal antibodies. Journal of Immunology, 139, 1823-1829.
14. Martin, H., Bruecher, J., Claudé, R. & Hoelzer, D. (1993) Cumulative chemotherapy increases mafosfamide toxicity for normal progenitor cells in AML patients: rationale for cryopreserving adapted-dose purged marrow early in first complete remission. Bone Marrow Transplantation, 12, 495-499.
15. Mayer, R.J., Davis, R.B., Schiffer, C.A., Berg, D.T., Powell, B.L., Schulman, P., Omura, G.A., Moore, J.O., McIntyre, O.R. & Frei, E. (1994) Intensive post remission chemotherapy in adults with acute myeloid leukemia. New England Journal of Medicine, 331, 896-903.
16. Moos, M., Schmohl, D., Fischer, K., Schlenk, R., Diehl, D., Haas, R. & Döhner, H. (1996) Prospective monitoring of minimal residual disease by polymerase chain reaction in patients with acute myeloid leukemia expressing CBFβ/MYH11 fusion transcripts. (Abstract). Blood, 88, 562a.
17. Sanz, M.A., de la Rubia, J., Sanz, G.F., Martin, G., Martinez, J., Jarque. I., Sempere, A., Gomis, F., Senent, L., Soler, M.A., Lopez, M.F., Arilla, J., Cario, N., Guinot, R. Palau, J., Tudela, M. & Marty, M.L. (1993) Busulfan plus cyclophosphamide followed by autologous blood stem cell transplantation for patients with acute myeloblastic leukemia in remission: a report from a single institution. Journal of Clinical Oncology 11, 1661-1667.
18. Schmitz, N., Linch, D.C., Dreger, P., Goldstone, A.H., Boogaerts, M.A., Ferrant, A., Demuynck, H.M., Link, H., Zander, A., Barge, A. & Borkett, K. (1996) Randomised trial of filgrastim-mobilised peripheral progenitor cell transplantation in lymphoma patients. Lancet. 347, 353-357.
19. + hematopoietic stem cells in the peripheral blood of high dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony stimulating factor. Blood, 74, 1905-1914.
20. - progenitor cells. Blood, 77, 1218-1227.
21. Watts, M.J., Addison, L. & Linch, D.C. (1996) Comparison of progenitor cell mobilisation by glycosylated and non-glycosylated G-CSF given at a dose of 5 μg/kg/day to normal volunteers. (Abstract). Blood, 88, 395a.
22. Weick, J.K., Kopecky, K.J., Applebaum, F.R., Head, D.R., Kingsbury, L.L., Balcerzak, S.P., Bickers, J.N., Hynes, H.E., Welborn, J.L., Simon, S.R. & Grever, M. (1996) A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group Study. Blood, 88, 2841-2851.